Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Spore
  4. Molecular Farming (Biopharming)

Molecular Farming (Biopharming)

Using plants as living bioreactors to produce vaccines, antibodies, and therapeutic proteins
Back to SporeView interactive version

Molecular farming (biopharming) uses plants or plant cell cultures as bioreactors to produce vaccines, antibodies, and enzymes. Fast-growing species like Nicotiana benthamiana are transiently expressed with agroinfiltration or viral vectors, yielding high-value proteins within weeks rather than months required for stainless-steel bioreactors. Downstream processing recovers GMP-grade products at lower capital intensity, leveraging existing agricultural acreage.

Pharma companies, governments, and startups deploy biopharming for pandemic preparedness, orphan drugs, and enzymes for industrial processes where flexibility and rapid scale-up matter. Firms such as Kentucky BioProcessing and Medicago have demonstrated field-to-vial timelines measured in weeks, while plant-made dairy proteins and cosmetic actives expand non-pharma use cases.

Future systems will integrate controlled-environment greenhouses, automated infiltration robots, and digital batch records connected to regulatory portals. Key hurdles involve consistent glycosylation profiles, containment protocols to prevent gene flow, and regulatory harmonization between agriculture and pharma authorities. Contract manufacturing networks and insurance structures for crop-as-factory models will drive broader adoption.

TRL
6/9Demonstrated
Impact
4/5
Investment
4/5
Category
Applications

Related Organizations

Moolec Science logo
Moolec Science

United Kingdom · Company

95%

Produces animal proteins (like pork protein) inside plant crops such as soy and pea ('Piggy Sooy').

Developer
Nobell Foods logo
Nobell Foods

United States · Startup

95%

Produces casein (milk protein) in soybeans to create stretchy plant-based cheese.

Developer
Protalix BioTherapeutics logo
Protalix BioTherapeutics

Israel · Company

95%

Develops plant-cell-expressed recombinant therapeutic proteins, including an FDA-approved drug for Gaucher disease.

Developer
BioBetter logo
BioBetter

Israel · Startup

90%

Uses tobacco plants to produce complex growth factors (GFs) required for the cultivated meat industry.

Developer
Bright Biotech

United Kingdom · Startup

90%

Expresses high-value recombinant proteins in the chloroplasts of plants for higher yields.

Developer
Core Biogenesis logo
Core Biogenesis

France · Startup

90%

Produces growth factors and cytokines in oilseed plants for the cell therapy and cultivated meat markets.

Developer
IngredientWerks logo
IngredientWerks

United States · Startup

90%

Produces heme protein in corn for the alternative meat industry.

Developer
Miruku logo
Miruku

New Zealand · Startup

90%

Engineers oilseed crops to produce dairy proteins and fats within the plant seeds.

Developer
ORF Genetics logo
ORF Genetics

Iceland · Company

90%

Uses genetically modified barley grain to produce growth factors for cosmetics and biotechnology.

Developer
Tiamat Sciences logo
Tiamat Sciences

United States · Startup

85%

Uses vertical farming to produce biomolecules and proteins in plants at a fraction of the cost of bioreactors.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Applications
Applications
Precision Biological Production

Engineered microbes producing proteins, fats, and biomaterials through controlled fermentation

TRL
7/9
Impact
5/5
Investment
5/5
Software
Software
Genomic & Microbial Design Platforms

AI-driven platforms that engineer crop genomes and symbiotic microbes for resilience and yield

TRL
5/9
Impact
5/5
Investment
5/5
Hardware
Hardware
Advanced Fermentation Bioreactors

Modular bioreactors with real-time sensing and automated control for microbial protein and biomass production

TRL
6/9
Impact
5/5
Investment
5/5
Applications
Applications
Cultured Meat Production

Growing animal meat from cells in bioreactors instead of raising livestock

TRL
6/9
Impact
5/5
Investment
5/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions